Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the most common liver cancer and one of the leading causes of cancer-related deaths in the world. Multiple immunotherapeutic approaches have been investigated to date, and immunotherapy has become the new standard of care therapy in HCC. However, the current role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gok Yavuz, Betul, Hasanov, Elshad, Lee, Sunyoung S, Mohamed, Yehia I, Curran, Michael A, Koay, Eugene J, Cristini, Vittorio, Kaseb, Ahmed O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478438/
https://www.ncbi.nlm.nih.gov/pubmed/34595140
http://dx.doi.org/10.2147/JHC.S322289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478438/
https://www.ncbi.nlm.nih.gov/pubmed/34595140
http://dx.doi.org/10.2147/JHC.S322289

Ejemplares similares